SIRT1 and breast carcinoma: For instance, Sahoo et al. demonstrated that SIRT1 inhibition by sirtinol, CHIC-35, or EX527 decreases the proliferation and migration of MCF-7 breast cancer cells [217], thus suggesting SIRT1 as a cell progression factor in breast cancer.